These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11369156)

  • 1. Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study.
    Mercadante S; Serretta R; Casuccio A
    J Pain Symptom Manage; 2001 May; 21(5):369-72. PubMed ID: 11369156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine as an adjuvant therapy to opioids in cancer pain: a randomized, double-blind, placebo-controlled trial.
    Suh SY; Choi YS; Oh SC; Kim YS; Cho K; Bae WK; Lee JH; Seo AR; Ahn HY
    J Pain Symptom Manage; 2013 Oct; 46(4):474-82. PubMed ID: 23498965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain.
    Watanabe S; Pereira J; Tarumi Y; Hanson J; Bruera E
    J Palliat Med; 2008 May; 11(4):570-4. PubMed ID: 18454609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
    Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
    J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-low-dose Naloxone as an Adjuvant to Patient Controlled Analgesia (PCA) With Morphine for Postoperative Pain Relief Following Lumber Discectomy: A Double-blind, Randomized, Placebo-controlled Trial.
    Firouzian A; Gholipour Baradari A; Alipour A; Emami Zeydi A; Zamani Kiasari A; Emadi SA; Kheradmand B; Hadadi K
    J Neurosurg Anesthesiol; 2018 Jan; 30(1):26-31. PubMed ID: 27673505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
    Southworth S; Peters J; Rock A; Pavliv L
    Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial.
    Israel FJ; Parker G; Charles M; Reymond L
    J Pain Symptom Manage; 2010 Mar; 39(3):548-54. PubMed ID: 20083373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial of oral morphine for chronic non-cancer pain.
    Moulin DE; Iezzi A; Amireh R; Sharpe WK; Boyd D; Merskey H
    Lancet; 1996 Jan; 347(8995):143-7. PubMed ID: 8544547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study.
    Mercadante S; Arcuri E; Tirelli W; Villari P; Casuccio A
    Tumori; 2002; 88(3):239-42. PubMed ID: 12195763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
    Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
    J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.
    Mercadante S; Arcuri E; Tirelli W; Casuccio A
    J Pain Symptom Manage; 2000 Oct; 20(4):246-52. PubMed ID: 11027905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment.
    Roca G; Aguilar JL; Gomar C; Mazo V; Costa J; Vidal F
    Pain; 1996 Dec; 68(2-3):239-43. PubMed ID: 9121810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR).
    Coluzzi PH; Schwartzberg L; Conroy JD; Charapata S; Gay M; Busch MA; Chavez J; Ashley J; Lebo D; McCracken M; Portenoy RK
    Pain; 2001 Mar; 91(1-2):123-30. PubMed ID: 11240084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial.
    Stockler M; Vardy J; Pillai A; Warr D
    J Clin Oncol; 2004 Aug; 22(16):3389-94. PubMed ID: 15310785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen plus caffeine in the treatment of tension-type headache.
    Diamond S; Balm TK; Freitag FG
    Clin Pharmacol Ther; 2000 Sep; 68(3):312-9. PubMed ID: 11014413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
    Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
    Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
    Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
    J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.